Lenalidomidă Dr. Reddy’s (Lenalidomide)

Lenalidomide binds to cereblon, a component of the CRL4‑E3 ubiquitin ligase complex, altering the degradation of specific transcription factors. This leads to reduced cytokine production, inhibition of new blood‑vessel formation, and promotion of programmed cell death in malignant cells, thereby enhancing immune‑mediated tumor control.

The dose of lenalidomide is individualized by the prescribing clinician based on the specific indication, disease stage, renal function, and patient tolerance. Dosage regimens are detailed in the product labeling and must be followed exactly as directed by a qualified healthcare professional.

Lenalidomide is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because of a high risk of fetal harm. Women of child‑bearing potential must use effective contraception. The drug is also not recommended while breastfeeding, as it may pass into breast milk and affect the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Both lenalidomide and thalidomide belong to the immunomodulatory imide drug (IMiD) class, but lenalidomide is more potent, has a shorter half‑life, and generally exhibits a more favorable safety profile, especially regarding peripheral neuropathy. Clinical studies often favor lenalidomide for multiple myeloma and certain MDS subtypes due to higher response rates.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. Do not refrigerate or freeze the tablets, and discard any product that shows signs of damage or discoloration.

Lenalidomidă Dr. Reddy’s is taken orally, usually once daily, with or without food, as directed by the treating physician. Swallow the tablet whole with a glass of water; do not crush, split, or chew unless the prescribing information specifically allows it.

The most serious risks include deep vein thrombosis or pulmonary embolism, severe neutropenia that can lead to life‑threatening infections, and the potential development of secondary primary malignancies. Patients should be monitored closely for signs of clotting, infection, and any new cancerous lesions throughout therapy.

Lenalidomidă Dr. Reddy’s should not be used by pregnant women, individuals with known hypersensitivity to lenalidomide or any component of the formulation, and patients with uncontrolled active infections or severe renal impairment without dose adjustment. Clinicians must also avoid use in patients who cannot comply with required contraception measures.